Feasibility Study of BMAC Enhanced CABG

Summary

Patients undergoing CABG will have 60 mL of bone marrow drawn, concentrated in a SmartPRep2 centrifuge and have the concentrated nucleated cells injected into areas of ischemic myocardium

Timeline

Start

2011-02

Primary completion

2013-04

Completion

2013-04

Outcome

Outcome not reported

Stopped: “Pilot results in change to protocol, new study needed.”

Drugs

Indications